Clinical Use of Inotropic Therapy for Heart Failure: Looking Backward or Forward? Part I: Inotropic Infusions During Hospitalization

This publication has 39 references indexed in Scilit:

• Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial
  The Lancet, 2002
• Intermittent inotropic therapy in an outpatient setting: A cost-effective therapeutic modality in patients with refractory heart failure
  American Heart Journal, 1996
• Heart failure in septic shock
  Critical Care Medicine, 1990
• Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial Infarction
  New England Journal of Medicine, 1988
• Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
  The American Journal of Cardiology, 1987
• Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy
  The American Journal of Cardiology, 1987
• New Positive Inotropic Agents in the Treatment of Congestive Heart Failure
  New England Journal of Medicine, 1986
• Amrinone in the treatment of chronic cardiac failure
  Journal of the American College of Cardiology, 1984
• The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy
  American Heart Journal, 1983
• Dobutamine: A New Synthetic Cardioactive Sympathetic Amine
  New England Journal of Medicine, 1979